Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05705362

Simple Crossover Versus Side Branch Opening in Patients With Non-Left Main Bifurcation Lesion

Conditions: Coronary Artery Disease

Sex: All
Ages: 19 Years – N/A
Phase: NA
Enrollment: 1000
Sponsor: Keimyung University Dongsan Medical Center

Summary

Hypothesis:Simple crossover strategy would be non-inferior to SB opening strategy in the risk of target lesion failure (TLF) in patients with angiographically compromised SB (visually SB stenosis ≥50%) after provisional MV stenting for non-left main bifurcation lesion.A total of 1000 patients (500 per each group) with the angiographically compromised SB (visually SB stenosis ≥50%) after provisional MV stenting for non-left main bifurcation lesion will be enrolled. Patients will be randomized to either the simple crossover strategy group or SB opening strategy group at the time of enrollment with 1:1 ratio. Stratified randomization according to participating center, clinical presentation (acute coronary syndrome or stable ischemic heart disease), and type of bifurcation lesions (true or non-true) will be performed.

Eligibility Criteria

Inclusion Criteria:(1) Subject must be at least 19 years of age(2) Patients with non-left main bifurcation lesion (SB diameter ≥2.3 mm)(3) Target lesions amenable for 1-stenting with provisional SB approach by operators' decision(4) Angiographically compromised SB (visual SB stenosis ≥50%) after provisional MV stentingExclusion Criteria:(1) Target lesions requiring elective 2-stenting technique by operators' decision (Observation Group 1)*(2) Patients who inevitably require SB intervention after MV stenting, as follows. (Observation Group 2)*Reduced SB TIMI flow (≤2) after MV stentingSB dissection after MV stenting (≥ Type C)(3) Patients without SB compromise after MV stenting (visually SB stenosis <50%) (Observation Group 3)*(4) Cardiogenic shock (Killip class IV) at presentation(5) Patients with significant valvular heart disease or severe left ventricular systolic dysfunction (ejection fraction <35%)(6) Pregnancy or breast feeding(7) Non-cardiac co-morbid conditions are present with life expectancy <1 year or that may result in protocol non-compliance (per site investigator's medical judgment)(8) Unwillingness or inability to comply with the procedures described in this protocol

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05705362). StuddyBuddy aggregates publicly available trial information.